Literature DB >> 2949033

Clinical aspects with regard to the occurrence of an endogenous luteinizing hormone surge in gonadotropin-induced normal menstrual cycles.

J F Van Uem, J E Garcia, H C Liu, Z Rosenwaks.   

Abstract

A decline in serum E2 the day before laparoscopy indicated that ovulation had occurred in 16 cycles stimulated with exogenous gonadotropins for the purpose of in vitro fertilization (IVF). In contrast to 18 control cycles with rising E2 values after human chorionic gonadotropin (hCG) administration and without evidence of ovulation, the onset of the endogenous luteinizing hormone (LH) surge had been initiated. From this study, it is believed that the onset of an endogenous LH surge can be identified by the terminal preovulatory E2 pattern. Further, the incidence of an endogenous LH surge in gonadotropin-induced menstrual cycles and the present clinical approach of the Norfolk IVF program to this phenomenon are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2949033     DOI: 10.1007/bf01133245

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  13 in total

1.  The program for in vitro fertilization at Norfolk.

Authors:  H W Jones; G S Jones; M C Andrews; A Acosta; C Bundren; J Garcia; B Sandow; L Veeck; C Wilkes; J Witmyer; J E Wortham; G Wright
Journal:  Fertil Steril       Date:  1982-07       Impact factor: 7.329

2.  Update on in vitro fertilization.

Authors:  G S Jones
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

3.  Effects of luteinizing hormone on steroidogenesis by thecal tissue from human ovarian follicles in vitro.

Authors:  K P McNatty; A Makris; R Osathanondh; K J Ryan
Journal:  Steroids       Date:  1980-07       Impact factor: 2.668

4.  The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human.

Authors:  G S Jones; J E Garcia; Z Rosenwaks
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

5.  Human menopausal gonadotropin stimulation in monkeys: blockade of the luteinizing hormone surge by a highly transient ovarian factor.

Authors:  B A Littman; G D Hodgen
Journal:  Fertil Steril       Date:  1984-03       Impact factor: 7.329

6.  Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women.

Authors:  A P Ferraretti; J E Garcia; A A Acosta; G S Jones
Journal:  Fertil Steril       Date:  1983-12       Impact factor: 7.329

7.  Three years of in vitro fertilization at Norfolk.

Authors:  H W Jones; A A Acosta; M C Andrews; J E Garcia; G S Jones; J Mayer; J S McDowell; Z Rosenwaks; B A Sandow; L L Veeck
Journal:  Fertil Steril       Date:  1984-12       Impact factor: 7.329

8.  Ovarian and peripheral blood inhibin concentrations increase with gonadotropin treatment in immature rats.

Authors:  V W Lee; J McMaster; H Quigg; J Findlay; L Leversha
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

9.  Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.

Authors:  J E Garcia; G S Jones; A A Acosta; G Wright
Journal:  Fertil Steril       Date:  1983-02       Impact factor: 7.329

10.  Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization.

Authors:  L L Veeck; J W Wortham; J Witmyer; B A Sandow; A A Acosta; J E Garcia; G S Jones; H W Jones
Journal:  Fertil Steril       Date:  1983-05       Impact factor: 7.329

View more
  4 in total

1.  Failure of fertilization in in vitro fertilization: the "occult" male factor.

Authors:  S Oehninger; A A Acosta; T Kruger; L L Veeck; J Flood; H W Jones
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-08

2.  The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.

Authors:  D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

Review 3.  Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.

Authors:  Luiz Eduardo T Albuquerque; Leopoldo O Tso; Humberto Saconato; Maria Cecília R M Albuquerque; Cristiane R Macedo
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

4.  Atypical response to luteinizing hormone-releasing hormone (LH-RH) agonist (suprefact nasal) in induction of ovulation in in vitro fertilization (IVF).

Authors:  J B Lessing; J R Cohen; I Yovel; A Amit; M P David; M R Peyser
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.